Conclusion:
COVID 19 pandemic has resulted in many burdens on the social, financial, psychological, and physical aspects. COVID 19 vaccines were recently introduced to help combat the effects of this pandemic. These vaccines are effective with great immunogenicity; however, their complete safety is not yet established. Therefore, the potential benefits of the vaccines are outweighed by the potential benefits, and more studies are needed to further unveil all the potential risks from these vaccines. MS risk of Relapse decreases with age and those with stable disease. However, the development of MS relapse following the vaccine administration should be considered a potential side effect.
Data availability statement:The data that support the findings of this study are available from the corresponding author upon reasonable request.
Conflict of interest: The authors have no conflict of interest to declare.